Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets. | Funct Integr Genomics | 2023 | 36625940 | PubTator, text mining | PubMed |
| LINC00173 facilitates tumor progression by stimulating RAB1B-mediated PA2G4 and SDF4 secretion in nasopharyngeal carcinoma. | Mol Oncol | 2023 | 36606322 | PubTator, text mining | PubMed |
| lncRNA-mediated ceRNA network in bladder cancer. | Noncoding RNA Res | 2023 | 36605618 | PubTator, text mining | PubMed |
| lncRNA UCA1 inhibits mitochondrial dysfunction of skeletal muscle in type 2 diabetes mellitus by sequestering miR-143-3p to release FGF21. | Cell Tissue Res | 2023 | 36602629 | PubTator, text mining | PubMed |
| Cell cycle related long non-coding RNAs as the critical regulators of breast cancer progression and metastasis. | Biol Res | 2023 | 36597150 | PubTator, text mining | PubMed |
Expression of concern to "Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease through the inhibition of the PI3K/Akt signaling pathway" [Int. Immunopharmacol. 75 (2019) 105734]. | Int Immunopharmacol | 2023 | 36596085 | PubTator, text mining | PubMed |
| Correction: LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway. | J Cancer Res Clin Oncol | 2023 | 36595046 | PubTator, text mining | PubMed |
| Retraction Notice to: Inflammatory-Related P62 Triggers Malignant Transformation of Mesenchymal Stem Cells through the Cascade of CUDR-CTCF-IGFII-RAS Signaling. | Mol Ther Nucleic Acids | 2023 | 36570674 | PubTator, text mining | PubMed |
| Clinical and Molecular Attributes and Evaluation of Pancreatic Cystic Neoplasm. | Biochim Biophys Acta Rev Cancer | 2023 | 36535512 | PubTator, text mining | PubMed |
| Roles of RNA-binding proteins in neurological disorders, COVID-19, and cancer. | Hum Cell | 2023 | 36528839 | PubTator, text mining | PubMed |
| Long non-coding RNA UCA1 regulates MPP+-induced neuronal damage through the miR-671-5p/KPNA4 pathway in SK-N-SH cells. | Metab Brain Dis | 2023 | 36515797 | PubTator, text mining | PubMed |
| ZNF281 drives hepatocyte senescence in alcoholic liver disease by reducing HK2-stabilized PINK1/Parkin-mediated mitophagy. | Cell Prolif | 2023 | 36514923 | PubTator, text mining | PubMed |
| Non-coding RNA regulation of integrins and their potential as therapeutic targets in cancer. | Cell Oncol (Dordr) | 2023 | 36512308 | PubTator, text mining | PubMed |
| Clinical Value and Mechanism of Long Non-Coding RNA UCA1 in Acute Respiratory Distress Syndrome Induced by Cardiopulmonary Bypass. | Heart Lung Circ | 2023 | 36463076 | PubTator, text mining | PubMed |
| Long noncoding RNA UCA1 promotes the expression and function of P-glycoprotein by sponging miR-16-5p in human placental BeWo cells. | FASEB J | 2023 | 36459147 | PubTator, text mining | PubMed |
| Systematic characterization and biological functions of non-coding RNAs in glioblastoma. | Cell Prolif | 2023 | 36457281 | PubTator, text mining | PubMed |
| m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer. | J Mol Endocrinol | 2023 | 36367225 | PubTator, text mining | PubMed |
| lncRNASNP v3: an updated database for functional variants in long non-coding RNAs. | Nucleic Acids Res | 2023 | 36350671 | PubTator, text mining | PubMed |
| Silencing of UCA1 attenuates the ox-LDL-induced injury of human umbilical vein endothelial cells via miR-873-5p/MAPK8 axis. | Kaohsiung J Med Sci | 2023 | 36326096 | PubTator, text mining | PubMed |
| LncTarD 2.0: an updated comprehensive database for experimentally-supported functional lncRNA-target regulations in human diseases. | Nucleic Acids Res | 2023 | 36321659 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=26